Matches in Wikidata for { <http://www.wikidata.org/entity/Q81050174> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q81050174 description "artículu científicu espublizáu en setiembre de 2005" @default.
- Q81050174 description "im September 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81050174 description "scientific article published on 01 September 2005" @default.
- Q81050174 description "wetenschappelijk artikel" @default.
- Q81050174 description "наукова стаття, опублікована у вересні 2005" @default.
- Q81050174 name "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and" @default.
- Q81050174 name "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and" @default.
- Q81050174 type Item @default.
- Q81050174 label "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and" @default.
- Q81050174 label "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and" @default.
- Q81050174 prefLabel "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and" @default.
- Q81050174 prefLabel "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and" @default.
- Q81050174 P1433 Q81050174-68337396-1387-4237-971C-93A525550F3A @default.
- Q81050174 P1476 Q81050174-AC1900F3-C9CA-4B61-80A0-D9A073281CFF @default.
- Q81050174 P2093 Q81050174-255224B1-175A-478E-BF54-2229D5B92153 @default.
- Q81050174 P2093 Q81050174-43CF2DB4-787D-4201-9082-E37F96BA23E3 @default.
- Q81050174 P2093 Q81050174-4410E954-4E22-463D-8B51-94B726B4A9A0 @default.
- Q81050174 P2093 Q81050174-44945C7E-8A8F-4564-855B-2CA327602B9D @default.
- Q81050174 P2093 Q81050174-69B62F29-FD10-4DE1-B397-78B32F3FD3F6 @default.
- Q81050174 P2093 Q81050174-74B4D17C-DC36-4075-816F-CDCAF80811A9 @default.
- Q81050174 P2093 Q81050174-829AAFAA-073D-4160-BA13-8C590C53B53D @default.
- Q81050174 P2093 Q81050174-8787EAC8-2869-4FA0-AE27-227A52A2389A @default.
- Q81050174 P2093 Q81050174-9E4B2CF0-E1F0-49B0-AE8A-0BB601F43BAB @default.
- Q81050174 P2093 Q81050174-BD8699F3-E13A-43CE-92BA-577ACAB13CE6 @default.
- Q81050174 P2093 Q81050174-CE65DBAA-4C80-4B6F-9A70-C705B1570A43 @default.
- Q81050174 P2093 Q81050174-DEAC2B6D-3AC8-43C3-A12D-E2AF020FAF9D @default.
- Q81050174 P2093 Q81050174-DF7AC8EC-11B2-47A5-978B-DB7EBA1EF807 @default.
- Q81050174 P2093 Q81050174-E7FC8991-1976-43A1-AF71-1388B3724E17 @default.
- Q81050174 P304 Q81050174-A36C8436-53CD-4C6E-97EB-F5C76CD97D3C @default.
- Q81050174 P31 Q81050174-D74FA4C2-B1A6-447A-AA56-287152D331EC @default.
- Q81050174 P356 Q81050174-C968F1BC-AB46-4359-8DCE-6579B321C68E @default.
- Q81050174 P433 Q81050174-F8EEDAB5-E483-446F-A6A7-AEA16F2C9567 @default.
- Q81050174 P478 Q81050174-8289F30D-05D3-4EDA-91A4-84E8DD716625 @default.
- Q81050174 P50 Q81050174-C345A284-9241-433A-AB89-C4CD915BCEBE @default.
- Q81050174 P577 Q81050174-CF4DDFBA-98AF-4CD6-ADCE-8DED37D4131C @default.
- Q81050174 P698 Q81050174-12E681D0-B286-40CE-9C3A-D861D1F06064 @default.
- Q81050174 P921 Q81050174-1B8053FB-C6DC-4918-AA7D-FF19386D2EC1 @default.
- Q81050174 P921 Q81050174-2251319F-8DC0-4CAD-9C1A-EB4CC3AC7086 @default.
- Q81050174 P921 Q81050174-8AE510BA-5621-43E9-8CA3-B830033C1DFB @default.
- Q81050174 P921 Q81050174-A5F4BE3B-4303-4C27-8B84-0327A4BC0914 @default.
- Q81050174 P921 Q81050174-CBB8E500-7F38-4DAF-8591-8F76B41B629F @default.
- Q81050174 P921 Q81050174-EBFB4F8B-03FB-4138-9E49-D5D474E80368 @default.
- Q81050174 P356 01.CAD.0000175587.31940.19 @default.
- Q81050174 P698 16096436 @default.
- Q81050174 P1433 Q4774128 @default.
- Q81050174 P1476 "Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC" @default.
- Q81050174 P2093 "C Thomssen" @default.
- Q81050174 P2093 "C Tsekov" @default.
- Q81050174 P2093 "D Fritze" @default.
- Q81050174 P2093 "I Chernozemsky" @default.
- Q81050174 P2093 "J B Vermorken" @default.
- Q81050174 P2093 "Kh Merkle" @default.
- Q81050174 P2093 "L Sirakova" @default.
- Q81050174 P2093 "M Kaufmann" @default.
- Q81050174 P2093 "N Marschner" @default.
- Q81050174 P2093 "N Stuart" @default.
- Q81050174 P2093 "P Chilingirov" @default.
- Q81050174 P2093 "R Souchon" @default.
- Q81050174 P2093 "S Loibl" @default.
- Q81050174 P2093 "U Kleeberg" @default.
- Q81050174 P304 "871-877" @default.
- Q81050174 P31 Q13442814 @default.
- Q81050174 P356 "10.1097/01.CAD.0000175587.31940.19" @default.
- Q81050174 P433 "8" @default.
- Q81050174 P478 "16" @default.
- Q81050174 P50 Q11163000 @default.
- Q81050174 P577 "2005-09-01T00:00:00Z" @default.
- Q81050174 P698 "16096436" @default.
- Q81050174 P921 Q12859063 @default.
- Q81050174 P921 Q238512 @default.
- Q81050174 P921 Q422232 @default.
- Q81050174 P921 Q425745 @default.
- Q81050174 P921 Q42824827 @default.
- Q81050174 P921 Q6934595 @default.